Daily Compliance News: August 13, 2025. The Bad App Store Ratings Edition
AGG Talks: Cross-Border Business Podcast - Episode 19: The Rise of Korean Investment in the Southeast U.S.
Corruption, Crime, and Compliance - A Deep Dive into KT Corp's SEC Settlement for FCPA Violations
Nota Bene Episode 137: Asia Q3 Check In: Vaccine Rollouts and China’s Capital Markets with Paul Kim
Nota Bene Episode 88: Asia Check In: COVID Recovery, China’s National Security Law for Hong Kong, and Navigating a U.S.-China Cold War with Paul Kim
Nota Bene Episode 80: South Korea’s Bellwether on the Pandemic Market Recovery with Paul Kim
Reports have suggested that on April 2, 2025, President Donald Trump will likely announce reciprocal tariffs pursuant to the International Emergency Economic Powers Act (IEEPA) (50 U.S.C. 1701 et seq.) and investigations...more
By now, many of us are using AI, advising others about how to use AI, and waiting for some legislative miracle to give us some guardrails for what we can or cannot be doing with AI. A lot of effort has been put into tracking...more
Welcome to the third edition of our AI Legal News Summer Roundup! After five class actions were filed between June 28 and July 11 (as reported on in our first edition of this series), on July 21, another class action lawsuit...more
On 29 March and 20 April 2023, Switzerland adopted new measures against Russia, following those recently adopted by the EU as part of a tenth sanction package. More industrial, high-tech and aviation goods are now banned for...more
Seyfarth maintains 11 offices across the United States, as well as international offices in London, Shanghai, Melbourne, Sydney, and Hong Kong. Our Global Mobility Team is staffed with a group of professionals that includes...more
As evidenced recently in the United States, it may be difficult to tell what categories of inventions are eligible for patent protection in foreign jurisdictions. To further complicate issues, standards of eligible subject...more
Country-Specific “Exemptions” - Last week Seyfarth Shaw published an alert concerning the 25% global tariff on imported steel articles, which commenced at midnight on March 23, 2018, and which would have applied to the...more
Here are our picks for the top-five most significant foreign market developments in the world of biosimilars in 2016: Various guidance documents have been published this year further defining regulatory requirements for...more
On July 22, 2016, Australia’s Therapeutic Goods Administration approved Samsung Bioepis’s biosimilar of Amgen’s Enbrel (etanercept), which is approved for treatment of rheumatoid arthritis. Samsung Bioepis’s product, called...more